Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer

PURPOSE: The outcome of the luminal oestrogen receptor-positive (ER +) subtype of breast cancer (BC) is highly variable and patient stratification needs to be refined. We assessed the prognostic significance of oestrogen-regulated solute carrier family 39 member 6 (SLC39A6) in BC, with emphasis on E...

Descripción completa

Detalles Bibliográficos
Autores principales: Althobiti, Maryam, El-sharawy, Khloud A., Joseph, Chitra, Aleskandarany, Mohammed, Toss, Michael S., Green, Andrew R., Rakha, Emad A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Preclinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505289/
https://www.ncbi.nlm.nih.gov/pubmed/34453638
http://dx.doi.org/10.1007/s10549-021-06336-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505289/
https://www.ncbi.nlm.nih.gov/pubmed/34453638
http://dx.doi.org/10.1007/s10549-021-06336-y

Ejemplares similares